Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
KYMR
#885
Kymera Therapeutics, Inc. Common Stock
91.350
0
+1.44%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.44%
Monthly Change
+25.93%
6 month change
+54.57%
Year Change
+54.57%
Previous Close
90.050
0
Open
91.380
0
Bid
Ask
Low
91.350
0
High
91.380
0
Volume
150
Markets
US Stock Market
Healthcare
KYMR
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
News
Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway
모건 스탠리, 카이메라 테라퓨틱스 목표 주가 하향 조정
Morgan Stanley cuts Kymera Therapeutics stock price target on pipeline progress
RBC 캐피털, 키메라 테라퓨틱스 목표가 상향
카이메라 테라퓨틱스, RBC 캐피탈, 목표 주가 상향
RBC Capital raises Kymera Therapeutics price target on pipeline progress
RBC Capital raises Kymera Therapeutics price target on pipeline
Stifel, Kymera Therapeutics에 ’매수’ 등급 재확인, 목표가 $114
Stifel reiterates Buy rating on Kymera Therapeutics stock at $114
Kymera Q4 2025 slides: pipeline advances despite revenue miss
Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates
카이메라 테라퓨틱스, 5억 달러 규모의 시장 조성 주식 공모 개시